Clin Transl Allergy. 2019 Mar 11;9:16.
DOI: 10.1186/s13601-019-0252-0. eCollection 2019.
Methods : MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients.
Stakeholders : Include patients, health care professionals (pharmacists and physicians), authorities, patient’s associations, private and public sectors.
Results : MASK is deployed in 23 countries and 17 languages. 26,000 users have registered.
EU grants (2018) : MASK is participating in EU projects (POLLAR: impact of air POLLution in Asthma and Rhinitis, EIT Health, DigitalHealthEurope, Euriphi and Vigour).
Lessons learnt : (i) Adherence to treatment is the major problem of allergic disease, (ii) Self-management strategies should be considerably expanded (behavioural), (iii) Change management is essential in allergic diseases, (iv) Education strategies should be reconsidered using a patient-centred approach and (v) Lessons learnt for allergic diseases can be expanded to chronic diseases.